PMID- 27566775 OWN - NLM STAT- MEDLINE DCOM- 20180102 LR - 20180205 IS - 1758-1052 (Electronic) IS - 0956-4624 (Linking) VI - 28 IP - 3 DP - 2017 Mar TI - Immune reconstitution inflammatory syndrome associated with secondary syphilis. PG - 302-305 LID - 10.1177/0956462416664469 [doi] AB - Immune reconstitution inflammatory syndrome (IRIS) is a condition associated with paradoxical worsening and/or new onset of an opportunistic infection in HIV patients following the initiation of anti-retroviral therapy or switching to more potent antiretroviral therapy (ART) regimen. Although IRIS associated with many opportunistic infections (OIs) has been well reported, syphilis has very rarely been mentioned in this regard. A 52-year-old male, diagnosed with AIDS six weeks ago, presented with the disseminated non-pruritic painless skin rash. He denied any fever, cough, shortness of breath, and joint pain or swelling. The patient had no similar symptoms, genital ulcers, or any medical illness in the past. CD4 cell count and viral load were 40 cells/mm(3) and 280,000 copies/ml, respectively, while screening tests for OIs including rapid plasma reagin test, quantiferon, cryptococcal antigen, and toxoplasma tests were negative at the time of HIV diagnosis. After three days of initiation of anti-retroviral therapy, he developed the above-mentioned skin rash. Repeat rapid plasma regain (RPR) test at this time was also negative. Punch biopsy of the skin lesion demonstrated findings suggestive of secondary syphilitic lesions, which was confirmed by immunostain. The repeat RPR, CD4 cell count, and viral load showed a titer of 1:256, 257 cells/mm(3), and 5000 copies/ml, respectively. His skin rashes faded away, and RPR titer trended down on treatment with benzathine penicillin without discontinuation of ART. The presence of an IRIS response does not predict overall HIV or OI treatment responses, and discontinuation of ART is not generally recommended as the benefits of treating HIV infection outweighs the risk associated with IRIS. FAU - Frunza-Stefan, Simona AU - Frunza-Stefan S AD - 1 Department of Internal Medicine, Wyckoff Heights Medical Center, Brooklyn, NY, USA. FAU - Acharya, Gyanendra AU - Acharya G AD - 1 Department of Internal Medicine, Wyckoff Heights Medical Center, Brooklyn, NY, USA. FAU - Kazlouskaya, Viktoryia AU - Kazlouskaya V AD - 1 Department of Internal Medicine, Wyckoff Heights Medical Center, Brooklyn, NY, USA. FAU - Vukasinov, Paunel AU - Vukasinov P AD - 1 Department of Internal Medicine, Wyckoff Heights Medical Center, Brooklyn, NY, USA. FAU - Chiou, Yushan AU - Chiou Y AD - 3 Ackerman Academy of Dermatopathology, NY, USA. FAU - Thet, Zeyar AU - Thet Z AD - 2 Division of Infectious Disease, Department of Internal Medicine, Wyckoff Heights Medical Center, Brooklyn, NY USA. LA - eng PT - Case Reports PT - Journal Article DEP - 20160927 PL - England TA - Int J STD AIDS JT - International journal of STD & AIDS JID - 9007917 RN - RIT82F58GK (Penicillin G Benzathine) RN - Syphilis, secondary SB - IM MH - *Antiretroviral Therapy, Highly Active MH - CD4 Lymphocyte Count MH - HIV Infections/complications/*drug therapy MH - Humans MH - Immune Reconstitution Inflammatory Syndrome/diagnosis/*etiology/immunology/pathology MH - Male MH - Middle Aged MH - Penicillin G Benzathine/*therapeutic use MH - Syphilis/*complications/diagnosis/drug therapy MH - Syphilis Serodiagnosis MH - Treatment Outcome MH - Viral Load OTO - NOTNLM OT - HIV OT - Highly active antiretroviral therapy OT - IRIS OT - North America OT - syphilis EDAT- 2016/08/28 06:00 MHDA- 2018/01/03 06:00 CRDT- 2016/08/28 06:00 PHST- 2016/08/28 06:00 [pubmed] PHST- 2018/01/03 06:00 [medline] PHST- 2016/08/28 06:00 [entrez] AID - 0956462416664469 [pii] AID - 10.1177/0956462416664469 [doi] PST - ppublish SO - Int J STD AIDS. 2017 Mar;28(3):302-305. doi: 10.1177/0956462416664469. Epub 2016 Sep 27.